Dore GJ, Hajarizadeh B. Elimination of hepatitis C virus in Australia: laying the foundation. Infect Dis Clin North Am 2018;32(2):269–79. .https://www.ncbi.nlm.nih.gov/pubmed/29778255
Hellard M, Rolls DA, Sacks-Davis R, Robins G, Pattison P, Higgs P, et al. The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs. Hepatology 2014;60(6):1861–70. https://www.ncbi.nlm.nih.gov/pubmed/25163856
Papaluca T, McDonald L, Craigie A, Gibson A, Desmond P, Wong D, et al. Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care. J Hepatol 2019;70(5):839–46. https://www.ncbi.nlm.nih.gov/pubmed/30654067
Richmond JA, Sheppard-Law S, Mason S, Warner SL. The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals. Patient Prefer Adherence 2016;10:2479–89. https://www.ncbi.nlm.nih.gov/pubmed/28008234